Multi-Chem Current Liabilities
The Current Liabilities of Multi-Chem (AWZ.SI) as of Sep 26, 2026 is 131.60 M SGD. In the previous year, Current Liabilities was 158.52 M SGD — a change of -16.98% (lower).
Get this data via API
Financial Data API
Current Liabilities
131.60 MSGD
YoY
-16.98%
Last updated:
The Multi-Chem Current Liabilities history
3 Years
10 Years
25 Years
Max
| YEAR | Current Liabilities | YoY |
|---|---|---|
| 131.60 MSGD | -16.98% | |
| 158.52 MSGD | -0.11% | |
| 158.69 MSGD | -9.28% | |
| 174.91 MSGD | +34.04% | |
| 130.49 MSGD | +7.56% | |
| 121.32 MSGD | -19.75% | |
| 151.18 MSGD | +20.14% | |
| 125.84 MSGD | +1.29% | |
| 124.24 MSGD | +48.78% | |
| 83.50 MSGD | +4.64% | |
| 79.80 MSGD | -18.08% | |
| 97.41 MSGD | -19.28% | |
| 120.68 MSGD | +69.02% | |
| 71.40 MSGD | +0.56% | |
| 71.00 MSGD | +40.32% | |
| 50.60 MSGD | +15.26% | |
| 43.90 MSGD | -22.44% | |
| 56.60 MSGD | -12.11% | |
| 64.40 MSGD | +46.70% | |
| 43.90 MSGD | +87.61% | |
| 23.40 MSGD | +72.06% | |
| 13.60 MSGD | +23.64% | |
| 11.00 MSGD | -5.17% | |
| 11.60 MSGD | — |
Multi-Chem Stock analysis
Frequently Asked Questions about Multi-Chem stock
Current Liabilities of Multi-Chem is 131.60 M SGD in 2026.
Current Liabilities of Multi-Chem changed from 158.52 M SGD to 131.60 M SGD, representing a -16.98% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Current Liabilities Multi-Chem since 2006 – with annual values, charts, and detailed analysis.
Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.
Current Liabilities's SGD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Multi-Chem historically and in real time.
Balance Sheet — Multi-Chem
All Key Metrics — Multi-Chem
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth